Religare Enterprises Limited (IN:RELIGARE)
:RELIGARE
Top Page
Religare Enterprises Limited
(RELIGARE)
Select Model
Select Model
Rating:62Neutral
Price Target:
₹214.00
▼(-14.16% Downside)
Action:ReiteratedDate:03/25/26
The score is primarily supported by strong revenue growth and healthy operating/free cash flow, but is held back by weaker profitability/ROE signals and a bearish technical setup (below key moving averages with negative MACD). Valuation is also less supportive due to the negative P/E and lack of dividend yield data.
Positive Factors
Diversified financial services franchise
A diversified business mix across lending, insurance distribution, healthcare services and capital markets reduces single-market dependence. This structural breadth supports revenue stability, cross-selling, and resilience to segment-specific shocks, aiding durable growth over months.
Negative Factors
Declining net profit margin
A falling net margin driven by rising operating costs erodes retained earnings and free cash conversion. If higher expenses are structural, profitability and the ability to fund growth or returns will be impaired over several quarters without sustained cost control or revenue mix improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified financial services franchise
A diversified business mix across lending, insurance distribution, healthcare services and capital markets reduces single-market dependence. This structural breadth supports revenue stability, cross-selling, and resilience to segment-specific shocks, aiding durable growth over months.
Read all positive factors
Religare Enterprises Limited (RELIGARE) vs. iShares MSCI India ETF (INDA)
Market Cap
₹74.57B
Dividend YieldN/A
Average Volume (3M)55.94K
Price to Earnings (P/E)―
Beta (1Y)0.60
Revenue Growth8.35%
EPS Growth-50.99%
CountryIN
Employees13,000
SectorFinancial
Sector Strength70
IndustryFinancial - Capital Markets
Share Statistics
EPS (TTM)-1.36
Shares Outstanding332,890,470
10 Day Avg. Volume70,962
30 Day Avg. Volume55,941
Financial Highlights & Ratios
PEG Ratio-1.29
Price to Book (P/B)3.00
Price to Sales (P/S)1.03
P/FCF Ratio4.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Religare Enterprises Limited Business Overview & Revenue Model
Company Description
Religare Enterprises Limited operates as an investment company in India and internationally. The company provides broking services in equities, currencies, and commodities; depository participant services; tax information network and income tax pe...
How the Company Makes Money
null...
Religare Enterprises Limited Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
65
Positive
Cash Flow
83
Very Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.06B | 73.18B | 61.91B | 43.19B | 31.89B | 24.01B |
| Gross Profit | 55.88B | 48.64B | 40.74B | 36.93B | 24.49B | 16.81B |
| EBITDA | 2.23B | 3.39B | 6.10B | 39.41B | -2.38B | 2.81B |
| Net Income | 1.05B | 1.25B | 2.33B | 869.31M | -15.44B | -5.08B |
Balance Sheet | ||||||
| Total Assets | 125.05B | 112.29B | 95.77B | 80.94B | 93.53B | 87.26B |
| Cash, Cash Equivalents and Short-Term Investments | 10.26B | 10.87B | 10.72B | 7.98B | 25.26B | 16.20B |
| Total Debt | 3.19B | 2.33B | 4.43B | 8.41B | 49.37B | 49.40B |
| Total Liabilities | 85.56B | 77.92B | 64.08B | 54.16B | 98.85B | 84.28B |
| Stockholders Equity | 29.06B | 25.16B | 23.43B | 20.58B | -9.82B | -470.86M |
Cash Flow | ||||||
| Free Cash Flow | 2.47B | 15.47B | 14.78B | 14.66B | 15.56B | 13.54B |
| Operating Cash Flow | 2.55B | 15.72B | 15.00B | 15.06B | 15.96B | 13.73B |
| Investing Cash Flow | -8.46B | -11.85B | -13.48B | -9.39B | -6.89B | -11.81B |
| Financing Cash Flow | 5.11B | -2.85B | -1.56B | -20.79B | 5.59B | -3.14B |
Religare Enterprises Limited Technical Analysis
Neutral
249.30
Price Trends
226.16
Negative
235.91
Negative
243.64
Negative
Market Momentum
-1.85
Negative
52.10
Neutral
52.32
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:RELIGARE, the sentiment is Neutral. The current price of 249.3 is above the 20-day moving average (MA) of 216.07, above the 50-day MA of 226.16, and above the 200-day MA of 243.64, indicating a neutral trend. The MACD of -1.85 indicates Negative momentum. The RSI at 52.10 is Neutral, neither overbought nor oversold. The STOCH value of 52.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:RELIGARE.
Religare Enterprises Limited Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ₹98.71B | 5.96 | ― | 2.15% | 7.08% | 7.69% | |
77 Outperform | ₹96.09B | 6.70 | ― | 1.05% | 8.09% | 2.68% | |
74 Outperform | ₹86.13B | 6.68 | ― | 2.42% | ― | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | ₹74.57B | -45.03 | ― | ― | 8.35% | -50.99% | |
56 Neutral | ₹61.89B | 19.93 | ― | 1.63% | 10.02% | -120.18% | |
46 Neutral | ₹107.67B | 13.80 | ― | 2.82% | 6.15% | -64.12% |
* Financial Sector Average
IN:RELIGARE
Religare Enterprises Limited
224.00
3.50
1.59%
IN:EQUITASBNK
Equitas Small Finance Bank Ltd.
54.24
-0.73
-1.33%
IN:KTKBANK
Karnataka Bank Ltd.
227.75
54.69
31.60%
IN:SOUTHBANK
South Indian Bank Limited
36.71
14.07
62.15%
IN:TMB
Tamilnad Mercantile Bank Limited
623.35
220.81
54.85%
IN:UJJIVANSFB
Ujjivan Small Finance Bank Ltd.
55.42
20.29
57.76%
Religare Enterprises Limited Corporate Events
Religare Grants 22,692 Stock Options Under ESOP 2019
Mar 30, 2026
Religare Enterprises Limited has granted 22,692 stock options under its Employee Stock Option Plan 2019 to eligible employees, in line with SEBI’s share-based employee benefits regulations. Each option is convertible into one equity share wi...
Religare Subsidiary Faces Rs 140 Crore Tax Demand, Plans Appeal and Rectification
Mar 18, 2026
Religare Enterprises has disclosed that its material subsidiary Care Health Insurance Limited has received two income tax assessment and demand orders from the Mumbai tax authorities for assessment years 2023-24 and 2024-25, raising a cumulative d...
Religare Subsidiary Care Health Insurance Gets IRDAI Show-Cause Notice
Mar 3, 2026
Care Health Insurance Limited, a material subsidiary of Religare Enterprises, has received a show-cause notice from the Insurance Regulatory and Development Authority of India following a thematic onsite inspection conducted in February 2025. The ...
Religare Publishes Q3 and 9M FY26 Earnings Call Transcript
Feb 20, 2026
Religare Enterprises Limited has released the official transcript of its Q3 and nine‑month FY 2026 earnings conference call held on February 16, 2026. The call covered the company’s operational and financial performance for the quarter...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.